The U.S. Food and Drug Administration (FDA) announced its intent to expand the use of unannounced inspections at foreign ...

C-Path quickly emerged as a pioneer in accelerating drug development by launching landmark consortia and earning early regulatory endorsements for innovative safety kidney biomarkers by FDA ...

Daré will host a conference call and live webcast today, May 13, 2025, at 4:30 p.m. Eastern Time to review financial results ...

Mineralys Therapeutics reports strong Q1 2025 results, announcing pivotal trial success for lorundrostat, a $201M equity raise, and progress toward ...

Agenus Inc (AGEN) reports a narrowed net loss and strategic advancements despite revenue decline and cash pressure in Q1 2025 ...

Resolutions have decriminalized psilocybin in cities across Western Washington. Studies show psychedelics can help people suffering from trauma, depression, and anxiety. And more people are ...

Sangamo Therapeutics Inc (SGMO) secures a major deal with Eli Lilly and advances its pipeline, while navigating funding needs ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial” or the "Company”), a clinical-stage biopharmaceutical company focused on ...

However, there is a catch, and it could be a big one when the drug comes in front of regulatory reviewers ... and it remains to be seen whether the FDA will be swayed the LUCIDITY data without ...

Recently, underscoring a commitment to national security, the White House and the Food and Drug Administration (FDA) issued separate ...